Deep Sleep
INGREDIENTS
DEEP SLEEP:
DEEP SLEEP complies with all Health Canada requirements for claims.
MÉLISSE CYRACOS®
A clinical study was conducted on 20 people aged 18 to 70 to scientifically demonstrate the anti-stress activity of Cyracos®. A group of volunteers with symptoms of anxiety and difficulty falling asleep were observed. This group was supplemented with 300 mg of Cyracos® 2 times daily. After 2 weeks of supplementation, the following results were observed in the group consuming Cyracos®:
Lactium®
Lactium® is a hydrolyzate of milk proteins with relaxing properties. Lactium® has been tested by numerous studies that have proven effective on stress symptoms and its safety. The anti-stress properties of Lactium® have been tested and scientifically confirmed at a dose of 167 mg / day. Lactium® does not cause disorders related to lactose intolerance. Each capsule of Plein Sommeil contains 84 mg of Lactium®.
HOP
Concentrate 5: 1 equivalent to 625 mg.
PASSIONFLOWER
It has the property of calming the nerves without depressing and to make sleeping so as to be as awake after a normal sleep. Each capsule of Deep Sleep contains 125 mg of Passionflower Concentrate 4: 1 equivalent to 500 mg.
MAGNESIUM CITRATE
Magnesium is involved in all phases of body relaxation. Each capsule of Deep Sleep contains 150 mg of magnesium citrate.
5-HTP
Several clinical studies have shown that 5-HTP produces good results for both normal sleepers and those with insomnia. It has the ability to increase the quality of sleep. Each capsule of Plein Sommeil contains 25 mg of 5-HTP.
MELATONIN
Melatonin helps restore the body's sleep-wake cycle. It is used to increase the total sleep time and to reduce the time required for falling asleep. Each capsule of Deep Sleep contains 1.5 mg of Melatonin.
DEEP SLEEP complies with all Health Canada requirements for claims.
MÉLISSE CYRACOS®
A clinical study was conducted on 20 people aged 18 to 70 to scientifically demonstrate the anti-stress activity of Cyracos®. A group of volunteers with symptoms of anxiety and difficulty falling asleep were observed. This group was supplemented with 300 mg of Cyracos® 2 times daily. After 2 weeks of supplementation, the following results were observed in the group consuming Cyracos®:
- An 18% reduction in the signs of anxiety.
- A 15% reduction in symptoms associated with stress.
- A 42% reduction in initial insomnia.
Lactium®
Lactium® is a hydrolyzate of milk proteins with relaxing properties. Lactium® has been tested by numerous studies that have proven effective on stress symptoms and its safety. The anti-stress properties of Lactium® have been tested and scientifically confirmed at a dose of 167 mg / day. Lactium® does not cause disorders related to lactose intolerance. Each capsule of Plein Sommeil contains 84 mg of Lactium®.
HOP
Concentrate 5: 1 equivalent to 625 mg.
PASSIONFLOWER
It has the property of calming the nerves without depressing and to make sleeping so as to be as awake after a normal sleep. Each capsule of Deep Sleep contains 125 mg of Passionflower Concentrate 4: 1 equivalent to 500 mg.
MAGNESIUM CITRATE
Magnesium is involved in all phases of body relaxation. Each capsule of Deep Sleep contains 150 mg of magnesium citrate.
5-HTP
Several clinical studies have shown that 5-HTP produces good results for both normal sleepers and those with insomnia. It has the ability to increase the quality of sleep. Each capsule of Plein Sommeil contains 25 mg of 5-HTP.
MELATONIN
Melatonin helps restore the body's sleep-wake cycle. It is used to increase the total sleep time and to reduce the time required for falling asleep. Each capsule of Deep Sleep contains 1.5 mg of Melatonin.
Intellectual property Licence CA1281ST1013 (Click here to know more : Intellectual Property)
USING ADVICE
Two (2) capsules 30 minutes before going to bed and another as needed if waking up 1 or 2 hours later.
WARNINGS
May create drowsiness. Avoid taking if you must drive. Keep out of the reach of children. Pregnant or lactating women should consult a doctor.
Types of insomnia
There are 2 types of insomnia:
HOPS
Uses or Purposes Recommended by Health Canada
Statement (s) stating:
Clinical studies referenced and accepted by Health Canada:
PASSIONFLOWER
Uses or Purposes Recommended by Health Canada
Statement (s) stating:
USING ADVICE
Two (2) capsules 30 minutes before going to bed and another as needed if waking up 1 or 2 hours later.
WARNINGS
May create drowsiness. Avoid taking if you must drive. Keep out of the reach of children. Pregnant or lactating women should consult a doctor.
Types of insomnia
There are 2 types of insomnia:
- Transient insomnia: the symptoms are related to a punctual situation that is often easily identifiable, ie a more stressful period in the office, a divorce, etc. This type of insomnia can last for several weeks.
- Chronic insomnia: the difficulty in sleeping should be at least 3 nights per week, for at least 1 month.
HOPS
Uses or Purposes Recommended by Health Canada
Statement (s) stating:
- Used (traditionally) in herbal medicine to help relieve agitation and / or nervousness (soothing). (EMEA 2007, Mills and Bone 2005, ESCOP 2003, Hoffmann 2003, Blumenthal et al. 2000, Bradley 1992, Grieve 1971 [1931])
- Used (traditionally) in herbal medicine to help relieve agitation and / or nervousness (soothing) and help to sleep (in times of mental stress).
- Used (traditionally) in herbal medicine to help sleep (in times of mental stress). (EMEA 2007, Mills and Bone 2005, ESCOP 2003, Hoffmann 2003, Blumenthal et al. 2000, Bradley 1992, Felter and Lloyd 1983 [1898])
- Used (traditionally) in herbal medicine as an aromatic bitter to help digestion and stimulate appetite (stomachic). (Mills and Bone 2005, Bradley 1992, Grieve 1971 [1931])
Clinical studies referenced and accepted by Health Canada:
- Barnes J, Anderson LA, Philipson JD. 2007. Herbal Medicines, 3e édition. London (GB): Pharmaceutical Press.
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC): American Pharmaceutical Association; 2002.
- Blumenthal M, Goldberg A, Brinkmann J, éditeurs. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Boullard B. Plantes Médicinales du Monde: Réalités et Croyances. Paris (FR): Éditions ESTEM; 2001.
- Bradley PR, editor. 1992. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 1. Bournemouth (GB): British Herbal Medicine Association.
- Brinker F. 2001. Herb Contraindications and Drug Interactions, 3e édition. Sandy (OR): Eclectic Medical Publications.
- Brinker F. Online Updates and Additions to Herb Contraindications and Drug Interactions, 3e édition. Sandy (OR): Eclectic Medical Publications; 2007. [Consulté le 21 novembre 2007]. Disponible en ligne à : http://www.eclecticherb.com/emp/updatesHCDI.html
- Bruneton J. Pharmacognosie, Phytochimie, Plantes Médicinales, 3e édition. Paris (FR): Technique & Documentation; 1999.
- Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy : a pathophysiologic approach, 5e édition. New York (NY) : The McGraw-Hill Companies, Inc.; 2002.
- EMEA 2007 : European Medicines Agency. London (UK) : European Medicines Agency; 2007. [Consulté le 31 juillet 2007]. Disponible en ligne à : http://www.emea.europa.eu.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2e édition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Felter HW, Lloyd JU. King's American Dispensatory, Volume 1, 18e édition. Sandy (OR): Eclectic Medical Publications; 1983 [Réimpression de la publication de 1898].
- Grieve M. 1971. A Modern Herbal, Volume 1. New York (NY): Dover Publications [Réimpression de la publication de 1931 Harcourt, Brace & Company].
- Hoffmann D. 2003. Medical Herbalism: The Science and Practice of Herbal Medicine. Rochester (VT): Healing Arts Press.
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. 1997. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press.
- Mills S, Bone K. 2005. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone.
- USDA 2008: ARS, National Genetic Resources Program. Germplasm Resources Information Network (GRIN). National Germplasm Resources Laboratory, Beltsville (MD). [Consulté le 21 janvier 2008]. Disponible en ligne à : http://www.ars-grin.gov/cgi-bin/npgs/html/tax_search.pl
- Barnes J, Anderson LA, Philipson JD. 2002. Herbal Medicines: A Guide for Healthcare Professionals, 2nd edition. London (GB): The Pharmaceutical Press.
- BHP 1983: British Herbal Pharmacopoeia. Cowling (GB): British Herbal Medical Association; 1983.
- Boon H, Smith M. The Botanical Pharmacy: The pharmacology of 47 Common Herbs. Kingston (Ontario): Quarry Press Inc.; 1999.
- Chevallier A. 1996. The Encyclopaedia of Medicinal Plants. New York (NY): Dorling Kindersley.
- Huang KC. The Pharmacology of Chinese Herbs. 2e édition. Boca Raton (FL) CRC Press; 1999.
- Small E, Catling PM. 1999. Canadian Medicinal Crops. Ottawa (ON): National Research Council of Canada Monograph Publishing Program, NRC Research Press.
- Wichtl M, éditeur. Herbal Drugs and Phytopharmaceuticals: A Handbook for Practice on a Scientific Basis, 3e édition. Stuttgart (D): Medpharm GmbH Scientific Publishers; 2004.
- Wiersema J, León B. 1999. World Economic Plants: A Standard Reference. Boca Raton (FL): CRC Press LLC.
PASSIONFLOWER
Uses or Purposes Recommended by Health Canada
Statement (s) stating:
- Used (traditionally) in herbal medicine to help relieve agitation and / or nervousness (soothing). (EMEA 2007)
- Used (traditionally) in herbal medicine to help sleep (in times of mental stress).
- Used (traditionally) in herbal medicine to help relieve agitation and / or nervousness (soothing) and help to sleep (in times of mental stress).
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC): American Pharmaceutical Association; 2002.
- Boullard B. Plantes Médicinales du Monde: Réalités et Croyances. Paris (FR): Éditions ESTEM; 2001.
- Brinker F. 2010. Online Updates and Additions to Herb Contraindications and Drug Interactions, 3e édition. Sandy (OR): Eclectic Medical Publications. [Updated 2010 July 13; Consulté le 30 janvier 2013]. Disponible en ligne à : http://www.eclecticherb.com/emp/updatesHCDI.html
- Bruneton J. Pharmacognosie, Phytochimie, Plantes Médicinales, 3e édition. Paris (FR): Technique & Documentation; 1999.
- Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy : a pathophysiologic approach, 5e édition. New York (NY) : The McGraw-Hill Companies, Inc.; 2002.
- EMEA 2007. European Medicines Agency. Community Monograph on. London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 31 October 2007. [Consulté le 20 mars 2008]. Disponible en ligne à : http://www.emea.europa.eu/pdfs/human/hmpc/passiflorae_herba/23096206enfin.pdf
- Porcher MH. 2005. Sorting Passiflora Names. Multilingual Multiscript Plant Name Database - A Work in Progress. Melbourne (AUS): The University of Melbourne, Faculty of Land & Food Resources. [Consulté le 20 mars 2008]. Disponible en ligne à : http://www.plantnames.unimelb.edu.au/Sorting/Passiflora.html
- USDA 2008: ARS, National Genetic Resources Program. Germplasm Resources Information Network (GRIN). National Germplasm Resources Laboratory, Beltsville (MD). [Consulté le 21 janvier 2008]. Disponible en ligne à : http://www.ars-grin.gov/cgi-bin/npgs/html/tax_search.pl
- Wichtl M, Anton R, éditeurs. Plantes thérapeutiques : Tradition, pratique officinale, sciences et thérapeutique, 2e édition. Paris (F) : Lavoisier; 2003
- Wiersema J, León B. 1999. World Economic Plants: A Standard Reference. Boca Raton (FL): CRC Press LLC.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2e édition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.